脑部放疗，上午比下午敏感许多！
( W( ?2 l8 r: L$ ]. L
' J# k' n5 k1 \; P) [' W, T' S* W$ q6 M: J1 ?9 Q
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.! x* ]! @6 x1 j/ ?) J( P/ I8 E
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
2 P1 U2 k; Y3 C( W$ |Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
( P1 B# x& ~$ g) j! ?0 O8 b+ ySourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.3 V* g l* w' B1 P
/ t+ q' M5 O! Q. C2 FAbstract
3 `6 H! z: v# v, V1 r @; wBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
3 O- v/ |8 z2 Q$ x+ G: r- `% A, s7 E! ^. T: R) L/ L! ?& t
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
" ~' {! ^) v- a9 }& m* E2 K% H7 P- j* ]& [+ T/ m% Y) q
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).6 M/ D! P4 s$ R# S
0 g% m: `' q+ g) fCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.4 }1 t- |" ^' F6 f$ q1 z$ ?: b
3 D5 b9 l8 x ] x4 E6 ]
|
显身卡
